SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-254135
Filing Date
2023-10-11
Accepted
2023-10-11 16:02:52
Documents
13
Period of Report
2023-10-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d516537d8k.htm   iXBRL 8-K 28181
2 EX-99.1 d516537dex991.htm EX-99.1 12611
  Complete submission text file 0001193125-23-254135.txt   164009

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20231011.xsd EX-101.SCH 2846
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20231011_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20231011_pre.xml EX-101.PRE 10810
7 EXTRACTED XBRL INSTANCE DOCUMENT d516537d8k_htm.xml XML 3230
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 231320714
SIC: 2834 Pharmaceutical Preparations